Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and (1)H-MR spectroscopy compared with histology (subgroup in the RAXO trial)

BACKGROUND: Colorectal cancer liver metastases respond to chemotherapy and targeted agents not only by shrinking, but also by morphologic and metabolic changes. The aim of this study was to evaluate the value of advanced magnetic resonance imaging (MRI) methods in predicting treatment response and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Uutela, A., Ovissi, A., Hakkarainen, A., Ristimäki, A., Lundbom, N., Kallio, R., Soveri, L.M., Salminen, T., Ålgars, A., Halonen, P., Ristamäki, R., Nordin, A., Blanco Sequeiros, R., Rinta-Kiikka, I., Lantto, E., Virtanen, J., Pääkkö, E., Liukkonen, E., Saunavaara, J., Ryymin, P., Lammentausta, E., Osterlund, P., Isoniemi, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332656/
https://www.ncbi.nlm.nih.gov/pubmed/34325107
http://dx.doi.org/10.1016/j.esmoop.2021.100208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332656/
https://www.ncbi.nlm.nih.gov/pubmed/34325107
http://dx.doi.org/10.1016/j.esmoop.2021.100208

Ejemplares similares